Skip to main content
PMC home page
Molecules logoLink to Molecules
. 2011 Apr 19;16(4):3371–3379. doi: 10.3390/molecules16043371

Salidroside Attenuates Hydrogen Peroxide-Induced Cell Damage Through a cAMP-Dependent Pathway

Shuang Guan 1, Wei Wang 1,†, Jing Lu 1,2,†, Wenhui Qian 2, Guoren Huang 2, Xuming Deng 1,*, Xuelin Wang 1,*
PMCID: PMC6260613  PMID: 21512445

Abstract

Salidroside, a major component of Rhodiola rosea L., has shown various pharmacological functions, including antioxidant effects, but the signal transduction pathway of its antioxidant effects is not very clear. In this study, we found that salidroside could attenuate hydrogen peroxide (H2O2)-induced HL-7702 cell damage, inhibit H2O2-induced cytosolic free Ca2+ ([Ca2+]i) elevation, scavenge reactive oxygen species (ROS) and increase 3’-5’-cyclic adenosine monophosphate (cAMP) level in a dose-dependent manner, but it couldn’t influence 3’-5’-cyclic guanosine monophosphate (cGMP) levels. Therefore, these results indicated that the antioxidant effects of salidroside were associated with down-regulation of [Ca2+]i, ROS occur via a cAMP-dependent pathway.

Keywords: salidroside, antioxidant, AMP, cGMP, [Ca2+]i, ROS

1. Introduction

Rhodiola rosea L. has been widely used for a long time in Traditional Chinese Medicine. Salidroside (р-hydroxyphenethyl-β-D-glucoside, C14H20O7, 300.30), as shown in Figure 1, has been identified as the most potent ingredient in this medicinal plant [1]. Some studies have shown that salidroside possesses various pharmacological functions, including anti-aging [2], anti-cancer [3,4,5], anti-viral [6,7,8], anti-inflammatory [9], neuroprotective [10,11], hepatoprotective [9], cardiomyocytes protective [12,13], anti-diabetic [14] and antioxidant effects [15,16].

Figure 1.

Figure 1

Open in a new tab

Structure of salidroside.

Oxidative damage, mediated by reactive oxygen species (ROS) has been thought as a major cause of atherosclerosis, cancer, liver disorder and the aging process [17]. In previously studies, people found that the antioxidant mechanism included [Ca2+]i and NO signaling pathways [18,19], thus it might involve the 3’-5’-cyclic adenosine monophosphate (cAMP)/3’-5’-cyclic guanosine monophosphate (cGMP)-dependent signaling pathway. To the best of our knowledge, no one has investigated the role of cAMP/cGMP in the antioxidant effects of salidroside, so the objective of the present paper was to examine the effects of salidroside on H2O2-induced oxidative damage, cAMP, cGMP; [Ca2+]i and ROS levels in HL-7702 cells to determine whether the cAMP/cGMP pathway participate in the antioxidant effects of salidroside. Our results would be benefitial for development of salidroside as a potential agent for treatment of oxidative stress-related diseases.

2. Results and Discussion

2.1. Protective Effect of Salidroside on H2O2-Induced Cell Damage

The protective effect of salidroside on H2O2-induced cell damage as determined by the MTT assay is shown in Figure 2. Incubating with H2O2(0.5 mM) for 100 min induced significant cell damage. Pretreatment with salidroside (0.03, 0.05, 0.1 μg/mL) could attenuate H2O2-induced cell damage in a dose-dependent manner (p < 0.05), though it couldn’t restore the damaged cells totally. Data are expressed as mean ± S.D. (n = 4). # p < 0.05 and ## p < 0.01 compared with Control.

Figure 2.

Figure 2

Open in a new tab

Protective effect of salidroside on H2O2-induced cell damage. Cells were treated with salidroside followed by H2O2 as described in 2.2 and cell viability was determined by MTT assay.

2.2. Salidroside Inhibited H2O2-Induced [Ca2+]i Elevation

We examined the effect of salidroside on [Ca2+]i. We found that incubating with H2O2(0.5 mM) for 100 min induced a significant [Ca2+]i elevation, while pre-incubation with salidroside dose dependently suppressed the elevation of [Ca2+]i (Figure 3). Data are expressed as mean ± S.D. (n = 4). * p < 0.05 and ** p < 0.01 compared with Control; # p < 0.05 and ## p < 0.01 compared with H2O2 group.

Figure 3.

Figure 3

Open in a new tab

Salidroside inhibited H2O2-induced [Ca2+]i elevation (Recorded by inverted fluorescence microscope, Motic AE31 200×). (a). Control; (b). H2O2; (c). 0.03 μg/mL salidroside + H2O2; (d). 0.05 μg/mL salidroside + H2O2; (e). 0.1 μg/mL salidroside + H2O2; (f). Statistical analysis of fluorescence intensity data with Motic Advanced Images 3.2 software (China). Cells were treated with salidroside followed by H2O2 as described in 2.2. and [Ca2+]i levels were determined with Fluo-3/AM fluorescent dye.

2.3. Effects of Salidroside on the Formation of cAMP and cGMP

We investigated the effects of salidroside on the level of cAMP/cGMP. As shown in Figure 4, H2O2 decreased the levels of cAMP (Figure 4a) and cGMP (Figure 4b) in HL-7702 cells. The decreased level of cAMP was restored by treatment with salidroside, while the decreased level of cGMP was not changed. It showed that salidroside exerts antioxidant effects by cAMP, not cGMP. Data are expressed as absorbance density (OD) and presented as mean ± S.D. (n = 4). * p < 0.05 and ** p < 0.01 compared with Control; # p < 0.05 and ## p < 0.01 compared with H2O2 group.

Figure 4.

Figure 4

Open in a new tab

(a). Effect of salidroside on cAMP level in cells; (b). Effect of salidroside on cGMP level in cells. Cells were treated with salidroside followed by H2O2 as described in 2.2.Contents of cAMP and cGMP were measured using human cyclic adenosine monophosphate Elisa kits and human cyclic guanosine monophosphate Elisa kits respectively.

2.4. Salidroside Inhibited H2O2-Induced ROS Elevation

We examined the effect of salidroside on intracellular ROS. We found that incubating with H2O2(0.5 mM) for 100 min induced ROS elevation significantly, while pre-incubation with salidroside dose dependently suppressed the elevation of ROS (Figure 5). Statistical analysis of fluorescence intensity data with Motic Advanced Images 3.2 software. Data were expressed as mean ± S.D. (n = 4). * p < 0.05 and ** p < 0.01 compared with Control; # p < 0.05 and ## p < 0.01 compared with H2O2 group.

Figure 5.

Figure 5

Open in a new tab

Salidroside inhibited H2O2-induced ROS elevation (Recorded by inverted fluorescence microscope, Motic AE31 200×). (a). Control; (b). H2O2; (c). 0.03 μg/mL salidroside + H2O2; (d). 0.05 μg/mL salidroside + H2O2; (e). 0.1 μg/mL salidroside + H2O2; (f). Statistical analysis of fluorescence intensity data with Motic Advanced Images 3.2 software. Cells were treated with salidroside followed by H2O2 as described in 2.2.

2.5. Discussion

Today, oxidative damages caused by ROS and oxidative stress play important roles in many diseases, such as endocrine disruption [18]. H2O2, a major source of ROS, has been used in many studies to trigger oxidative damage [19]. In order to further studying antioxidant mechanism of salidroside, we investigated the effects of salidroside on H2O2-induced oxidative damage, cAMP, cGMP; [Ca2+]i and ROS level in HL-7702 cells.

In this paper, we used H2O2 0.5 mM to trigger oxidative damage in HL-7702 cells. Incubating with H2O2 for 100 min induced significant cell damage. Salidroside (0.03, 0.05, 0.1 μg/mL) could attenuate H2O2-induced damage in a dose-dependent manner. It is suggested that salidroside at dose of 0.03, 0.05, 0.1 μg/mL could efficiently protect cells from oxidative damage.

There is a mutual relationship between calcium and ROS signaling, which affects the local Ca2+ homeostasis [20]. H2O2 induced an [Ca2+]i rise which could still be evoked upon [Ca2+]i withdrawal and mitochondrial uncoupling [21]. In our research, 0.5 mM H2O2 successfully increased the level of [Ca2+]i in HL-7702 cells. [Ca2+]i levels are critical to cell life and changes in [Ca2+]i will affect matrix synthesis, as well as other functions [22]. In this experiment, salidroside inhibited H2O2-induced [Ca2+]i and ROS level and might be used in Ca2+ overloading disease.

cAMP is one of the most important second messengers in regulating a wide variety of cellular events and processes, such as metabolism, gene expression, cell division, migration, exocytosis and secretion. In non-excitable cells the fluctuations of [Ca2+]i and [cAMP]i are often interrelated and linked via adenylate cyclase or phosphodiesterase [23]. Elevation of the cAMP level will decrease the [Ca2+]i, and our result is consistent with this. The increased level of cAMP participates in activating PKA and consequently this enzyme phosphorylates its substrate proteins. Thus, the increased level of cAMP is linked to the activation of PKA [24]. Salidroside influenced H2O2-induced cAMP level, so it might be linked PKA-mediated phosphorylation.

cGMP is an important secondary messenger synthesized by the guanylyl cyclases and is also included in many cellular events and processes. It is believed that cGMP is produced via the activation of guanylate cyclase in the presence or absence of NO. NO is produced by the activation of NOS and affect the formation of cGMP. cGMP could affect [Ca2+]i through direct inhibition of L-type Ca2+ channels [15]. cAMP and cGMP both are regulators of NO [25]. Salidroside couldn’t influence cGMP level, so the change of NO may be mediated via cAMP-depend pathway.

In the experiment, we found that salidroside attenuated H2O2-induced cell damage, inhibited H2O2-induced [Ca2+]i elevation, scavenged ROS at low dose through cAMP-dependent pathway. These findings suggested that antioxidant protection of salidroside was associated with the cAMP-dependent pathway and decrease of [Ca2+]i and ROS levels.

3. Experimental

3.1. Materials

Salidroside (standard material, purity >98%) was purchased from the National Institute for the Control of Pharmaceutical and Biological Products. 3-[4,5-Dimethyl-2-thiazolyl]-2,5-diphenyl-2-tetrazolium bromide (MTT) was purchased from Sigma (USA). Fluo-3/AM was obtained from Dojin Laboratories (Japan). 5-(and-6)-Chloromethyl-2’,7’-dichlorodihydrofluorescein diacetate, acetyl ester (CM-H2DCFDA) was obtained from Invitrogen (Molecular Probe), USA. RPMI 1640 was obtained from Gibco (USA). Human cyclic guanosine monophosphate ELISA kit and Human cyclic adenosine monophosphate ELISA kit were obtained from Blue Gene (Shanghai, China). FBS was obtained from Hangzhou (China). All other reagents were from commercial suppliers and of standard biochemical quality.

3.2. Protective Effect of Salidroside on H2O2-Induced Cell Damage

The human hepatocyte HL-7702 was obtained from SGST (China). The protective effect of salidroside was assessed by the MTT assay. Briefly, cells seeded on 96-well culture plates at 5 × 104/ well were incubated with salidroside for 24 h. Following exposure to H2O2 (0.5 mM) for 100 min, the MTT solution (10 μL, 5 mg/mL) was added into each well and made the final concentration 0.5 mg/mL, and then the plates were incubated for an additional 2 h. After the medium was removed, DMSO (100 μL) was added into each well before reading the microplates at 570 nm. Cell viability was expressed as absorbance density (OD).

3.3. Determination of [Ca2+]i

The [Ca2+]i was determined using Fluo-3/acetoxymethyl ester (Fluo-3/AM), described previously with slight modification [26]. Briefly, cells were loaded for 20 min at 37 °C with 20 μM Fluo-3/AM containing 1 μM pluronic acid F-127 for proper dispersal and 0.25 mM sulfinpyrazone, to inhibit the leakage of the Fluo-3 dye. Shortly before use, a sample of loaded cells was washed with Krebs-Ringer-Hepes (KRH) buffer (130 mM NaCl, 1.3 mM KCl, 2.2 mM CaCl2, 1.2 mM MgSO4, 1.2 mM KH2PO4, 10 mM Hepes, 10 mM glucose, pH 7.4), to remove nonhydrolyzed Fluo-3/AM. Fluorescence measurements were performed using an inverted fluorescence microscope (Motic AE31invert, Xiamen, China).

3.4. Measurement of cAMP and cGMP

Cells (5 × 104 /mL) were pre-incubated with various concentrations of salidroside for 48 h at 37 °C in 24-well culture plates, then incubated with H2O2 for 100 min. cAMP and cGMP were measured using the ELISA kits according to the manufacturer’s instructions. The levels of cAMP and cGMP were expressed by absorbance density (OD).

3.5. Measurement of ROS

The intracellular ROS levels of cells were determined using CM-H2DCFDA assay [26]. For these experiments, cells were incubated with phosphate-buffered saline (PBS) and 5 mM CM-H2DCFDA. As a control, cells were incubated with PBS only. As a positive control, cells were incubated with PBS, 5 mM CM-H2DCFDA, and 0.5 mM H2O2. After a 100 min incubation period with 0.5 mM H2O2, cells were trypsinized, washed, and resuspended in PBS. The levels of fluorescence intensity were immediately detected using an inverted fluorescent microscope (Motic AE31invert, Xiamen, China).

3.6. Statistical Analysis

All data were shown as means ± S.D. (standard deviation of the mean) Statistical analyses were performed using Student’s t-test and one-way analysis of variance (ANOVA). p < 0.05 was considered as statistically significant.

4. Conclusions

The data reported here firstly suggested that the antioxidant effects of salidroside were associated with down-regulation of [Ca2+]i, ROS and at least partly via cAMP-dependent pathway.

Acknowledgements

This study was financed by the Chinese postdoctoral station of Jilin University (Number 801091800604).

Footnotes

Sample Availability: Samples of the salidroside are available from the authors.

References and Notes

  • 1.Ma C.Y., Tang J., Wang H.X., Tao G.J., Gu X.H., Hu L. Preparative purification of salidroside from Rhodiola rosea by two-step adsorption chromatography on resins. J. Sep. Sci. 2009;32:185–191. doi: 10.1002/jssc.200800438. [DOI] [PubMed] [Google Scholar]
  • 2.Mao G.X., Deng H.B., Yuan L.G., Li D.D., Li Y.Y.Y., Wang Z. Protective role of salidroside against aging in a mouse model induced by D-galactose. Biomed. Environ. Sci. 2010;23:161–166. doi: 10.1016/S0895-3988(10)60047-5. [DOI] [PubMed] [Google Scholar]
  • 3.Hu X.L., Zhang X.Q., Qiu S.F., Yu D.H., Lin S.X. Salidroside induces cell-cycle arrest and apoptosis in human breast cancer cells. Biochem. Biophys. Res. Commun. 2010;398:62–67. doi: 10.1016/j.bbrc.2010.06.033. [DOI] [PubMed] [Google Scholar]
  • 4.Skopinska-Rozewska E., Malinowski M., Wasiutynski A., Sommer E., Furmanowa M., Mazurkiewicz M., Siwicki A.K. The influence of Rhodiola quadrifida 50% hydro-alcoholic extract and salidroside on tumor-induced angiogenesis in mice. Pol. J. Vet. Sci. 2008;11:97–104. [PubMed] [Google Scholar]
  • 5.Li M.H., Zhang G.Z., Wang Y.S. Effect of salidroside on salivary adenoid cystic carcinoma cells in vitro. Hua Xi Kou Qiang Yi Xue Za Zhi. 2008;36:312–315, 319. [PubMed] [Google Scholar]
  • 6.Zhu J.B., Wan X.Y., Zhu Y.P., Ma X.L., Zheng Y.W., Zhang T.B. Evaluation of salidroside in vitro and in vivo genotoxicity. Drug Chem. Toxicol. 2010;33:220–222. doi: 10.3109/01480540903373654. [DOI] [PubMed] [Google Scholar]
  • 7.Wang H.B., Ding Y.Y., Zhou J., Sun X.L., Wang S.W. The in vitro and in vivo antiviral effects of salidroside from Rhodiola rosea L. against coxsackievirus B3. Phytomedicine. 2009;16:146–155. doi: 10.1016/j.phymed.2008.07.013. [DOI] [PubMed] [Google Scholar]
  • 8.Zuo G.Y., Li Z.Q., Chen L.R., Xu X.J. Activity of compounds from Chinese herbal medicine Rhodiola kirilowii (Regel) Maxim against HCVNS3 serine protease. Antivir. Res. 2007;76:86–92. doi: 10.1016/j.antiviral.2007.06.001. [DOI] [PubMed] [Google Scholar]
  • 9.Wu Y.L., Piao D.M., Han X.H., Nan J.X. Protective effects of salidroside against acetaminophen-induced toxicity in mice. Biol. Pharm. Bull. 2008;31:1523–1529. doi: 10.1248/bpb.31.1523. [DOI] [PubMed] [Google Scholar]
  • 10.Zou Y.Q., Cai Z.Y., Mao Y.F., Li J.B., Deng X.M. Effects of salidroside-pretreatment on neuroethology of rats after global cerebral ischemia-reperfusion. Zhong Xi Yi Jie He Xue Bao. 2009;7:130–134. doi: 10.3736/jcim20090207. [DOI] [PubMed] [Google Scholar]
  • 11.Yu S., Liu M., Gu X., Ding F. Neuroprotective effects of salidroside in the pc12 cell model exposed to hypoglycemia and serum limitation. Cell. Mol. Neurobiol. 2008;28:1067–1078. doi: 10.1007/s10571-008-9284-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Liang X.Q., Xie P., Zhang Y., Shi T., Wang Q.J., Yan T.H. Effects of salidroside on myocardial ischemia/reperfusion injury in rats. Chin. J. Nat. Med. 2010;8:127–131. doi: 10.3724/SP.J.1009.2010.00127. [DOI] [Google Scholar]
  • 13.Wu T.J., Zhou H.P., Jin Z.X., Bi S.H., Yang X.L., Yi D.H., Liu W.Y. Cardioprotection of salidroside from ischemia/reperfusion injury by increasing N-acetylglucosamine linkage to cellular proteins. Eur. J. Pharmacol. 2009;613:93–99. doi: 10.1016/j.ejphar.2009.04.012. [DOI] [PubMed] [Google Scholar]
  • 14.Li H.B., Ge Y.K., Zheng X.X., Zhang L. Salidroside stimulated glucose uptake in skeletal muscle cells by activating AMP-activated protein kinase. Eur. J. Pharmacol. 2008;588:165–169. doi: 10.1016/j.ejphar.2008.04.036. [DOI] [PubMed] [Google Scholar]
  • 15.Zhang Q.H., Lazar M., Molino B., Rodriguez R., Davidov T., Su J., Tse J., Weiss H.R., Scholz P.M. Reduction in interaction between cGMP and cAMP in dog ventricular myocytes with hypertrophic failure. Amer. J. Physiol.-Heart Circ. Phy. 2005;289:H1251–H1257. doi: 10.1152/ajpheart.01234.2003. [DOI] [PubMed] [Google Scholar]
  • 16.Zhang Li., Yu H., Zhao X., Lin X., Tan C., Cao G., Wang Z. Neuroprotective effects of salidroside against beta-amyloid-induced oxidative stress in SH-SY5Y human neuroblastoma cells. Neurochem. Int. 2010;57:547–555. doi: 10.1016/j.neuint.2010.06.021. [DOI] [PubMed] [Google Scholar]
  • 17.Kim J.I., Kim H.H., Kim S., Lee K.T., Ham I.H., Whang W.K. Antioxidant compounds from quercus salicina blume stem. Arch. Pharm. Res. 2008;31:274–278. doi: 10.1007/s12272-001-1152-2. [DOI] [PubMed] [Google Scholar]
  • 18.Monroe R.K., Halvorsen S.W. Environmental toxicants inhibit neuronal Jak tyrosine kinase by mitochondrial disruption. Neurotoxicology. 2009;30:589–598. doi: 10.1016/j.neuro.2009.03.007. [DOI] [PubMed] [Google Scholar]
  • 19.Cai L., Wang H., Li Q., Qian Y.F., Yao W.B. Salidroside inhibits H2O2-induced apoptosis in PC12 cells by preventing cytochrome c release and inactivating of caspase cascade. Acta Biochim. Biophys. Sinica. 2008;40:796–802. [PubMed] [Google Scholar]
  • 20.Csordas G., Hajnoczky G. SR/ER-mitochondrial local communication: Calcium and ROS. Biochim. Biophys. Acta. 1787:1352–1362. doi: 10.1016/j.bbabio.2009.06.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Gerich F.J., Funke F., Hildebrandt B., Fasshauer M., Muller M. H2O2-mediated modulation of cytosolic signaling and organelle function in rat hippocampus. Pflugers Arch.-Eur. J. Phys. 2009;458:937–952. doi: 10.1007/s00424-009-0672-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.White R., Gibson J.S. The effect of oxygen tension on calcium homeostasis in bovine articular chondrocytes. J. Orthop. Surg. Res. 2010;5:27. doi: 10.1186/1749-799X-5-27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Mironov S.L., Skorova E., Taschenberger G., Hartelt N., Nikolaev V.O., Lohse M.J., Kugler S. Imaging cytoplasmic cAMP in mouse brainstem neurons. BMC Neurosci. 2009;10:29. doi: 10.1186/1471-2202-10-29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Cho H.J., Cho J.Y., Rhee M.H., Park H.J. Cordycepin (3’-deoxyadenosine) inhibits human platelet aggregation in a cyclic AMP- and cyclic GMP-dependent manner. Eur. J. Pharmacol. 2007;558:43–51. doi: 10.1016/j.ejphar.2006.11.073. [DOI] [PubMed] [Google Scholar]
  • 25.Hemmrich K., Gummersbach C., Paul N.E., Goy D., Suschek C.V., Kroncke K.D., Pallua N. Nitric oxide and downstream second messenger cGMP and cAMP enhance adipogenesis in primary human preadipocytes. Cytotherapy. 2010;12:547–553. doi: 10.3109/14653241003695042. [DOI] [PubMed] [Google Scholar]
  • 26.Yamashiro K., Sasano T., Tojo K., Namekata I., Kurokawa J., Sawada N., Suganami T., Kamei Y., Tanaka H., Tajima N., et al. Role of transient receptor potential vanilloid 2 in LPS-induced cytokine production in macrophages. Biochem. Biophs. Res. Commun. 2010;398:284–289. doi: 10.1016/j.bbrc.2010.06.082. [DOI] [PubMed] [Google Scholar]

Articles from Molecules are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES